CNSA Vascular Access Devices: Evidence Based Clinical Practice Guidelines: Online launch 3 November!
Vascular access devices are lifelines for patients with cancer for the administration of prescribed therapies and supportive care. Evidence-based management is key in the prevention of vascular access complications and premature removal.
The revised Cancer Nurses Society of Australia (CNSA) Vascular Access Devices: Evidence Based Clinical Practice Guidelines detail the latest evidence and recommendations for patients with cancer with peripheral intravenous cannulas and central venous access devices. Join us to celebrate the launch of these important guidelines on Wednesday 3 November!
The first topic is Patency: Occlusion Prevention and Management. Eight common clinical questions are answered and graded recommendations for clinical practice. Find out what CNSA recommends for patency assessment, flushing & locking practices, needleless connectors, occlusion management and more!
Join us to celebrate the launch of these important guidelines on Wednesday 3 November!
This launch event is available in Australia and will start at the following times per location:
WA: 4:00pm | NT: 5:30pm | QLD: 6:00pm | SA: 6:30pm | VIC / TAS / NSW / ACT: 7:00pm
|Tags:peripheral intravenous cathetercentral vascular access deviceseducationpatient safetyguidelinesevidence-based practice|